Side effects, images, and drug details for Enspryng - Inside Rx
Back to Search Results

Enspryng

Satralizumab-Mwge
Satralizumab is used to treat adults with neuromyelitis optica spectrum disorder (NMOSD). NMOSD is a rare, chronic autoimmune disease that causes inflammation in the central nervous system. This can lead to damage of the optic nerves, spinal cord, and/or brain. Satralizumab is used only if your body produces antibodies to a protein called aquaporin-4 (AQP4). Your doctor will test you for this antibody. Satralizumab may also be used for purposes not listed in this medication guide.
CHEMICAL NAME
Satralizumab-Mwge
DRUG TYPE
Neuromyelitis Optica Spectrum Disorder
Rx icon

Learn more about price differences between brand and generic drugs

Get the Inside Rx app

Frequently Asked Questions

Satralizumab affects your immune system. You may get infections more easily, even serious or fatal infections. Call your doctor if you have signs of infection (fever, chills, cough, tiredness, muscle pain, diarrhea, stomach cramps, increased urination, burning when you urinate, skin sores or redness, swelling or tenderness).

Similar Drugs

Brand Name Examples Supplied As Strength
Enspryng Syringe 120 Mg/Ml

Save up to 80% on brand & generic medications.